Lewis antigens and blood clots study
Part of Heart & circulation clinical trials.
This study looks at how certain markers on your blood cells (Lewis antigens) relate to clots in your legs or lungs. If you've had a clot before, this research might help understand why.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 78 years old.
- You have had a deep vein thrombosis (clot in a leg) or a pulmonary embolism (clot in a lung).
- You are not currently pregnant or in the postpartum period.
- You do not have severe liver problems or alcoholic cirrhosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood cell changes and immune system activity may relate to blood clots in specific veins or lungs. It may help researchers understand why clots happen “without a clear cause” and how to better predict risk.
This trial aims to learn more about blood clots, inflammation, and blood vessel problems. It may help researchers better understand these conditions and how they affect people.
This study looks at whether a specific kind of blood-cell change (“clonal hematopoiesis”) is linked to a lung blood clot (pulmonary embolism) that happened without a clear trigger. It compares people with unprovoked clots to people with provoked clots, after checking for inherited clotting risk factors.
This study tests personalized blood thinner treatments for people with blood clots in their lungs. It looks for patients who are older, have kidney problems, or have cancer, to see if adjusting the treatment helps them more.
This study looks at how the body stops bleeding or forms clots in people with bleeding or clotting disorders. It may help researchers understand these conditions better and improve evaluation tests.
This trial builds a database to study patterns in blood tests and blood smear findings that can suggest small blood clots in the body. Joining may help researchers learn how to recognize and track these changes over time.
Hear when a new Thromboembolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.